首页 > 最新文献

International Journal of Molecular and Cellular Medicine最新文献

英文 中文
Stigmasterol- an Acetylcholinesterase Inhibitor from Phormidium retzii with relevance to Alzheimer's disease Therapy. 麦角甾醇--一种来自 Phormidium retzii 的乙酰胆碱酯酶抑制剂,与阿尔茨海默氏症治疗有关。
Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2023-01-01 DOI: 10.22088/IJMCM.BUMS.12.2.100
Rincy Yesudas, Vinoth Kumar Thirumalairaj, Geetharamani Durairaj, Amrutha Chacko, Lakshmanasenthil Shanmugaasokan, Suja Gunasekaran

This study observed in vitro screening, purification and identification of cholinesterase inhibitors from the microalgae Phormidium retzii. Mixed microalgal culture was screened from freshwater samples for Phormidium sp. Single colony was purified and authenticated as P. retzii. Acetylcholinesterase (AChE) enzyme was purified from hRBC ghost. Sequential extraction of P. retzii was performed using organic solvents. Cholinesterase enzyme activity and its inhibition by various extracts were then tested. The active fractions were then subjected to partial purification and characterization. Petroleum ether extract of P. retzii showed maximum inhibition of 68.6 % against AChE while other solvent extracts showed no inhibition. Seven fractions were obtained from the active extract using thin layer chromatography. Among which fraction no. 5 showed maximum inhibition of 86.37 % towards AChE. Fraction no. 5 when subjected to GC-MS led to determination of the active principle as stigmasterol. The maximum inhibition of stigmasterol (0.45µM) was 81.2±0.08% with IC50 value of 0.214. Stigmasterol from P. retzii inhibited AChE projecting itself as safer drug for Alzheimer's disease with minimal side effects.

本研究观察了从微藻 Phormidium retzii 中提取的胆碱酯酶抑制剂的体外筛选、纯化和鉴定过程。从淡水样本中筛选出混合微藻培养物 Phormidium sp.乙酰胆碱酯酶(AChE)是从 hRBC 幽灵中纯化出来的。使用有机溶剂对 P. retzii 进行了连续提取。然后测试了胆碱酯酶的活性以及各种提取物对其的抑制作用。然后对活性馏分进行部分纯化和表征。P. retzii 的石油醚提取物对 AChE 的最大抑制率为 68.6%,而其他溶剂提取物则没有抑制作用。使用薄层色谱法从活性提取物中获得了七个馏分。其中 5 号馏分对 AChE 的最大抑制率为 86.37%。对 5 号馏分进行 GC-MS 分析后,确定其活性成分为豆固醇。豆固醇(0.45µM)的最大抑制率为 81.2±0.08%,IC50 值为 0.214。从 P. retzii 中提取的豆固醇可抑制 AChE,从而成为治疗阿尔茨海默病的更安全药物,且副作用极小。
{"title":"Stigmasterol- an Acetylcholinesterase Inhibitor from <i>Phormidium retzii</i> with relevance to Alzheimer's disease Therapy.","authors":"Rincy Yesudas, Vinoth Kumar Thirumalairaj, Geetharamani Durairaj, Amrutha Chacko, Lakshmanasenthil Shanmugaasokan, Suja Gunasekaran","doi":"10.22088/IJMCM.BUMS.12.2.100","DOIUrl":"10.22088/IJMCM.BUMS.12.2.100","url":null,"abstract":"<p><p>This study observed <i>in vitro</i> screening, purification and identification of cholinesterase inhibitors from the microalgae <i>Phormidium retzii</i>. Mixed microalgal culture was screened from freshwater samples for <i>Phormidium</i> sp. Single colony was purified and authenticated as <i>P. retzii</i>. Acetylcholinesterase (AChE) enzyme was purified from hRBC ghost. Sequential extraction of <i>P. retzii</i> was performed using organic solvents. Cholinesterase enzyme activity and its inhibition by various extracts were then tested. The active fractions were then subjected to partial purification and characterization. Petroleum ether extract of <i>P. retzii</i> showed maximum inhibition of 68.6 % against AChE while other solvent extracts showed no inhibition. Seven fractions were obtained from the active extract using thin layer chromatography. Among which fraction no. 5 showed maximum inhibition of 86.37 % towards AChE. Fraction no. 5 when subjected to GC-MS led to determination of the active principle as stigmasterol. The maximum inhibition of stigmasterol (0.45µM) was 81.2±0.08% with IC50 value of 0.214. Stigmasterol from <i>P. retzii</i> inhibited AChE projecting itself as safer drug for Alzheimer's disease with minimal side effects.</p>","PeriodicalId":14152,"journal":{"name":"International Journal of Molecular and Cellular Medicine","volume":"12 2","pages":"100-107"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10837910/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139681102","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Genetic Contribution of the Adrenergic, Cholinergic, and Serotonergic Systems to Leiomyoma Development and Treatment. 肾上腺素能、胆碱能和羟色胺能系统对子宫肌瘤发展和治疗的遗传贡献。
IF 1.5 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2023-01-01 DOI: 10.22088/IJMCM.BUMS.12.4.320
Ângel Inácio, Laura Aguiar, Raquel Carrilho, Patrícia Pires, Joana Ferreira, Luís Coelho, Mário Rui Mascarenhas, Luís Sardinha, Tiago Bilhim, João Pisco, Manuel Bicho, Maria Clara Bicho

The link between the autonomic nervous system and tumor biology is being unfold. We aim to study the contribution of genes of the adrenergic (ADBR2 - rs1042713, NM_000024.6:c.46G>A, NP_000015.2:p. Gly16Arg), cholinergic (CHRNA5 - rs16969968, NM_000745.3:c.1192G>A, NP_000736.2:p.Asp398Asn), and serotonergic systems (SLC6A4 - 5-HTTVNTR-intron2, HTR2A - rs6313, NM_000621.5:c.102C>T, NP_ 001365853 .1: p. Ser 34=) to gynecological tumorigenesis and their treatment by embolization. A total of 517 DNA samples from women were analyzed. Samples were genotyped by PCR, PCR-RFLP and EndPoint genotyping. Results show a statistically significant association between the AA genotype of the ADBR2 gene and GG genotype of the CHRNA5 gene with leiomyoma (OR = 2.311; p = 0.003 and OR = 2.165; p = 0.001, respectively), and the epistatic interaction between genotypes increases the risk (OR = 2.458; p= 0.043). The GG genotype (CHRNA5) shows a lower reduction of the volume of the main leiomyoma after treatment (p=0.015). Combination of the genotypes 12/12-AA (SLC6A4 - ADBR2) increases the risk to leiomyoma (OR = 2.540, p= 0.030). TT genotype of HTR2A gene in combination with any of the two risk genotypes (of ADBR2 or CHRNA5) increases substantially the risk (OR = 5.266, p = 0.006; OR = 6.364, p=0.007, respectively). We conclude that ADBR2 and CHRNA5 genes have a relevant role that is enhanced by the epistatic relationship with the genes HTR2A and SLC6A4. CHRNA5 gene may also be a modulator of the success of embolization. We confirm the contribution of the genetics of Autonomous Nervous System to tumor biology.

自律神经系统与肿瘤生物学之间的联系正在展开。我们旨在研究肾上腺素能系统(ADBR2 - rs1042713, NM_000024.6:c.46G>A, NP_000015.2:p. Gly16Arg)、胆碱能系统(CHRNA5 - rs16969968, NM_000745.3:c.1192G>A,NP_000736.2:p.Asp398Asn)和血清素能系统(SLC6A4 - 5-HTTVNTR-intron2, HTR2A - rs6313, NM_000621.5:c.102C>T, NP_ 001365853 .1: p. Ser 34=)对妇科肿瘤发生和栓塞治疗的影响。共分析了 517 份女性 DNA 样本。通过 PCR、PCR-RFLP 和 EndPoint 基因分型对样本进行了基因分型。结果显示,ADBR2 基因的 AA 基因型和 CHRNA5 基因的 GG 基因型与子宫肌瘤有统计学意义(OR = 2.311; p = 0.003 和 OR = 2.165; p = 0.001),基因型之间的表观交互作用会增加风险(OR = 2.458; p= 0.043)。基因型为 GG(CHRNA5)的患者在接受治疗后,主要子宫肌瘤的体积缩小幅度较小(p=0.015)。12/12-AA(SLC6A4 - ADBR2)基因型组合会增加患子宫肌瘤的风险(OR = 2.540,p= 0.030)。HTR2A 基因的 TT 基因型与两种风险基因型(ADBR2 或 CHRNA5)中的任何一种结合,都会大幅增加患癌风险(OR=5.266,p=0.006;OR=6.364,p=0.007)。我们的结论是,ADBR2 和 CHRNA5 基因具有相关作用,而与 HTR2A 和 SLC6A4 基因的表观关系增强了这种作用。CHRNA5 基因也可能是栓塞成功与否的调节因子。我们证实了自主神经系统遗传学对肿瘤生物学的贡献。
{"title":"Genetic Contribution of the Adrenergic, Cholinergic, and Serotonergic Systems to Leiomyoma Development and Treatment.","authors":"Ângel Inácio, Laura Aguiar, Raquel Carrilho, Patrícia Pires, Joana Ferreira, Luís Coelho, Mário Rui Mascarenhas, Luís Sardinha, Tiago Bilhim, João Pisco, Manuel Bicho, Maria Clara Bicho","doi":"10.22088/IJMCM.BUMS.12.4.320","DOIUrl":"10.22088/IJMCM.BUMS.12.4.320","url":null,"abstract":"<p><p>The link between the autonomic nervous system and tumor biology is being unfold. We aim to study the contribution of genes of the adrenergic (ADBR2 - rs1042713, NM_000024.6:c.46G>A, NP_000015.2:p. Gly16Arg), cholinergic (CHRNA5 - rs16969968, NM_000745.3:c.1192G>A, NP_000736.2:p.Asp398Asn), and serotonergic systems (SLC6A4 - 5-HTTVNTR-intron2, HTR2A - rs6313, NM_000621.5:c.102C>T, NP_ 001365853 .1: p. Ser 34=) to gynecological tumorigenesis and their treatment by embolization. A total of 517 DNA samples from women were analyzed. Samples were genotyped by PCR, PCR-RFLP and EndPoint genotyping. Results show a statistically significant association between the AA genotype of the ADBR2 gene and GG genotype of the CHRNA5 gene with leiomyoma (OR = 2.311; p = 0.003 and OR = 2.165; p = 0.001, respectively), and the epistatic interaction between genotypes increases the risk (OR = 2.458; p= 0.043). The GG genotype (CHRNA5) shows a lower reduction of the volume of the main leiomyoma after treatment (p=0.015). Combination of the genotypes 12/12-AA (SLC6A4 - ADBR2) increases the risk to leiomyoma (OR = 2.540, p= 0.030). TT genotype of HTR2A gene in combination with any of the two risk genotypes (of ADBR2 or CHRNA5) increases substantially the risk (OR = 5.266, p = 0.006; OR = 6.364, p=0.007, respectively). We conclude that ADBR2 and CHRNA5 genes have a relevant role that is enhanced by the epistatic relationship with the genes HTR2A and SLC6A4. CHRNA5 gene may also be a modulator of the success of embolization. We confirm the contribution of the genetics of Autonomous Nervous System to tumor biology.</p>","PeriodicalId":14152,"journal":{"name":"International Journal of Molecular and Cellular Medicine","volume":"12 4","pages":"320-334"},"PeriodicalIF":1.5,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11240054/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141616345","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Expression Assessment of the Helicobacter pyloribabA and sabA Genes in Patients with Peptic Ulcer, Duodenal Ulcer and Gastric Cancer. 幽门螺旋杆菌 abA 和 sabA 基因在消化性溃疡、十二指肠溃疡和胃癌患者中的表达评估
Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2023-01-01 DOI: 10.22088/IJMCM.BUMS.12.2.211
Javad Shokri Shirvani, Maryam Salehi, Amirmohammad Rezaei Majd, Farzin Sadeghi, Elaheh Ferdosi-Shahandashti, Soraya Khafri, Mehdi Rajabnia

Helicobacter pylori as a common gastrointestinal (GI) pathogen must possess certain virulence characteristics to colonize the stomach, evade host immune responses, and subsequently induce GI diseases. This research aimed to investigate the expression level of two important genes, the sialic acid-binding adherence (SabA) and the blood group antigen-binding adhesion (BabA) in H. pylori strains isolated from adult patients living in the northern part of Iran, and their association with peptic ulcer disease (PUD) and gastric cancer (GC). This cross-sectional study was carried out on adult patients referring to the GI clinic of the hospitals affiliated to Babol University of Medical Sciences, Iran. New cases diagnosed with gastritis, peptic ulcer or gastric cancer were included. Endoscopic-guided gastric biopsies were examined and H. pylori positive colonies were analyzed to determine the expression of babA and sabA genes, utilizing specific primers and the SYBR Green dye. Among 175 patients with mean age of 51.6±15.6 years, 101 (57.7%) of the individuals tested positive for H. pylori infection. Statistical analysis revealed a significant correlation between sabA (P=0.003) and babA (P=0.002) gene expression and development of PUD and GC. Smoking (P=0.052), gender (P=0.004) and positive babA gene expression (P=0.009) had the greatest association with occurrence of PUD or GC in H. pylori positive patients.  In summary, the presence of the sabA gene in people infected with H. pylori increased the risk of GC compared to gastritis, while, the presence of the babA gene was significantly increased in gastric ulcer patients. Considering the diversity of H. pylori isolates and the varying results observed in different geographical regions, further comprehensive studies are required to evaluate the function of these genes in H. pylori pathogenesis and their relationship with clinical outcomes.

幽门螺杆菌作为一种常见的胃肠道(GI)病原体,必须具备一定的毒力特征,才能在胃中定植,逃避宿主的免疫反应,进而诱发胃肠道疾病。本研究旨在调查从伊朗北部成年患者体内分离出的幽门螺杆菌菌株中两个重要基因--唾液酸结合粘附(SabA)和血型抗原结合粘附(BabA)的表达水平,以及它们与消化性溃疡病(PUD)和胃癌(GC)的关系。这项横断面研究的对象是到伊朗巴博勒医科大学附属医院消化道门诊就诊的成年患者。研究对象包括确诊为胃炎、消化性溃疡或胃癌的新病例。对内窥镜引导下的胃活检组织进行检查,并利用特定引物和 SYBR 绿色染料对幽门螺杆菌阳性菌落进行分析,以确定 babA 和 sabA 基因的表达情况。在平均年龄为 51.6±15.6 岁的 175 名患者中,101 人(57.7%)幽门螺杆菌感染检测呈阳性。统计分析显示,sabA(P=0.003)和 babA(P=0.002)基因表达与 PUD 和 GC 的发生有明显相关性。吸烟(P=0.052)、性别(P=0.004)和 babA 基因表达阳性(P=0.009)与幽门螺杆菌阳性患者发生 PUD 或 GC 的关系最大。 总之,与胃炎相比,幽门螺杆菌感染者体内存在 sabA 基因会增加患 GC 的风险,而胃溃疡患者体内存在 babA 基因会显著增加患 GC 的风险。考虑到幽门螺杆菌分离物的多样性以及在不同地理区域观察到的不同结果,需要进行进一步的综合研究,以评估这些基因在幽门螺杆菌发病机制中的功能及其与临床结果的关系。
{"title":"Expression Assessment of the <i>Helicobacter pylori</i><i>babA</i> and <i>sabA</i> Genes in Patients with Peptic Ulcer, Duodenal Ulcer and Gastric Cancer.","authors":"Javad Shokri Shirvani, Maryam Salehi, Amirmohammad Rezaei Majd, Farzin Sadeghi, Elaheh Ferdosi-Shahandashti, Soraya Khafri, Mehdi Rajabnia","doi":"10.22088/IJMCM.BUMS.12.2.211","DOIUrl":"10.22088/IJMCM.BUMS.12.2.211","url":null,"abstract":"<p><p><i>Helicobacter pylori</i> as a common gastrointestinal (GI) pathogen must possess certain virulence characteristics to colonize the stomach, evade host immune responses, and subsequently induce GI diseases. This research aimed to investigate the expression level of two important genes, the sialic acid-binding adherence (<i>SabA</i>) and the blood group antigen-binding adhesion (<i>BabA</i>) in <i>H. pylori</i> strains isolated from adult patients living in the northern part of Iran, and their association with peptic ulcer disease (PUD) and gastric cancer (GC). This cross-sectional study was carried out on adult patients referring to the GI clinic of the hospitals affiliated to Babol University of Medical Sciences, Iran. New cases diagnosed with gastritis, peptic ulcer or gastric cancer were included. Endoscopic-guided gastric biopsies were examined and <i>H. pylori</i> positive colonies were analyzed to determine the expression of <i>babA</i> and <i>sabA</i> genes, utilizing specific primers and the SYBR Green dye. Among 175 patients with mean age of 51.6±15.6 years, 101 (57.7%) of the individuals tested positive for H. pylori infection. Statistical analysis revealed a significant correlation between <i>sabA</i> (P=0.003) and <i>babA</i> (P=0.002) gene expression and development of PUD and GC. Smoking (P=0.052), gender (P=0.004) and positive <i>babA</i> gene expression (P=0.009) had the greatest association with occurrence of PUD or GC in <i>H. pylori</i> positive patients.  In summary, the presence of the <i>sabA</i> gene in people infected with <i>H. pylori</i> increased the risk of GC compared to gastritis, while, the presence of the <i>babA</i> gene was significantly increased in gastric ulcer patients. Considering the diversity of <i>H. pylori</i> isolates and the varying results observed in different geographical regions, further comprehensive studies are required to evaluate the function of these genes in <i>H. pylori</i> pathogenesis and their relationship with clinical outcomes.</p>","PeriodicalId":14152,"journal":{"name":"International Journal of Molecular and Cellular Medicine","volume":"12 2","pages":"211-219"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10837913/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139681098","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Optimization of Fluorapatite/Bioactive Glass Nanocomposite Foams as Bone Tissue Scaffold: An in Vivo Study. 氟磷灰石/生物活性玻璃纳米复合泡沫作为骨组织支架的优化:体内研究。
IF 1.5 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2023-01-01 DOI: 10.22088/IJMCM.BUMS.12.4.388
Seyedali Seyedmajidi, Maryam Seyedmajidi, Sina Haghanifar

The present study investigated the suitability of nanocomposite foams of fluorapatite and bioactive glass (FA /BG) in different weight ratios as scaffolds for bone tissue in rat tibia regeneration to determine the optimal composition. FA and BG nano powders with a weight ratio of 25% FA/75% BG (compound 1) and 75% FA/25% BG (compound 2) were used as precursors for gel casting to produce nanocomposite foams. Thirty rats were randomly divided into two equal groups. Disk-shaped samples of each compound were implanted into the tibias of 15 rats. After 15, 30, or 60 days, five rats from each group were sacrificed and subjected to radiological, histopathological, and histomorphometrical examination. Data were analyzed using SPSS software. No foreign body reaction was observed in either group at all intervals, and the bone-biomaterial junction was direct. Overall, the inflammation rate, and the number of blood vessels, osteoblasts, and osteoclasts decreased over time in both groups. However, the number of osteocytes, trabecular bone thickness, and the percentage of new bone formation increased, in contrast to the remaining biomaterial percentage. Most of the changes in the group implanted with compound 2 were significantly more significant and faster than in the other group. Although the composite with the higher percentage of FA was superior to the composite with the higher percentage of BG, considering the results of our previous similar studies, the composite with the same percentage of FA and BG is more favorable to be used as a substitute for bone tissue in the body.

本研究调查了不同重量比的氟磷灰石和生物活性玻璃(FA /BG)纳米复合泡沫作为大鼠胫骨再生骨组织支架的适用性,以确定最佳成分。将重量比分别为 25% FA/75% BG(化合物 1)和 75% FA/25% BG(化合物 2)的 FA 和 BG 纳米粉末用作凝胶浇注的前体,以生产纳米复合泡沫。30 只大鼠被随机分为两组。将每种化合物的盘状样品植入 15 只大鼠的胫骨中。15、30 或 60 天后,每组各牺牲 5 只大鼠,并对其进行放射学、组织病理学和组织形态学检查。数据使用 SPSS 软件进行分析。两组大鼠在所有时间间隔内均未观察到异物反应,骨-生物材料交界处是直接的。总体而言,随着时间的推移,两组的炎症率、血管、成骨细胞和破骨细胞数量均有所下降。然而,骨细胞数量、骨小梁厚度和新骨形成的百分比却增加了,这与剩余生物材料的百分比形成了对比。植入化合物 2 组的大多数变化明显比另一组更显著、更快。虽然FA比例较高的复合材料优于BG比例较高的复合材料,但考虑到我们之前类似研究的结果,FA和BG比例相同的复合材料更有利于用作体内骨组织的替代品。
{"title":"Optimization of Fluorapatite/Bioactive Glass Nanocomposite Foams as Bone Tissue Scaffold: An in Vivo Study.","authors":"Seyedali Seyedmajidi, Maryam Seyedmajidi, Sina Haghanifar","doi":"10.22088/IJMCM.BUMS.12.4.388","DOIUrl":"10.22088/IJMCM.BUMS.12.4.388","url":null,"abstract":"<p><p>The present study investigated the suitability of nanocomposite foams of fluorapatite and bioactive glass (FA /BG) in different weight ratios as scaffolds for bone tissue in rat tibia regeneration to determine the optimal composition. FA and BG nano powders with a weight ratio of 25% FA/75% BG (compound 1) and 75% FA/25% BG (compound 2) were used as precursors for gel casting to produce nanocomposite foams. Thirty rats were randomly divided into two equal groups. Disk-shaped samples of each compound were implanted into the tibias of 15 rats. After 15, 30, or 60 days, five rats from each group were sacrificed and subjected to radiological, histopathological, and histomorphometrical examination. Data were analyzed using SPSS software. No foreign body reaction was observed in either group at all intervals, and the bone-biomaterial junction was direct. Overall, the inflammation rate, and the number of blood vessels, osteoblasts, and osteoclasts decreased over time in both groups. However, the number of osteocytes, trabecular bone thickness, and the percentage of new bone formation increased, in contrast to the remaining biomaterial percentage. Most of the changes in the group implanted with compound 2 were significantly more significant and faster than in the other group. Although the composite with the higher percentage of FA was superior to the composite with the higher percentage of BG, considering the results of our previous similar studies, the composite with the same percentage of FA and BG is more favorable to be used as a substitute for bone tissue in the body.</p>","PeriodicalId":14152,"journal":{"name":"International Journal of Molecular and Cellular Medicine","volume":"12 4","pages":"388-400"},"PeriodicalIF":1.5,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11240056/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141616348","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Amyloid Beta Alters the Expression of microRNAs Regulating HMGCR and ABCA1 Genes in Astrocytes of C57BL/6J Mice. β改变C57BL/6J小鼠星形胶质细胞中调节HMGCR和ABCA1基因的微小RNA的表达。
Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2023-01-01 DOI: 10.22088/IJMCM.BUMS.12.1.30
Hossein Azizi Dariuni, Mehrnaz Karimi Darabi, Zahra Nazeri, Shirin Azizidoost, Alireza Kheiroallah, Azam Khedri, Maryam Cheraghzadeh

Dysregulation of brain cholesterol homeostasis causes the accumulation of extracellular protein deposits called amyloid plaques in the hippocampus which eventually leads to neuronal death, memory and learning deficits. The aim of the present study was to investigate the effect of beta amyloid on miRNAs regulating HMGCR and ABCA1 as cholesterol synthesis and homeostasis genes. Primary astrocytes were isolated from C57BL/6J mice, and were treated with 0.5 μM amyloid beta (Aβ). Expression levels of genes and miRNAs were measured by real-time PCR. In comparison to control, Aβ treatment resulted in a significant decrease in miR-96-5p expression as a positive and negative regulator of HMGCR and ABCA1, respectively. There was no significant increase in miR-27a-3p expression as a negative regulator of HMGCR. miR- 106b- 5p and miR-143-3p expressions were also dramatically decreased as ABCA1 negative regulators. Amyloid beta can alter the expression of major genes in the cholesterol homeostasis pathway via their regulatory miRNAs.

大脑胆固醇稳态的失调会导致海马体中被称为淀粉样蛋白斑块的细胞外蛋白质沉积的积累,最终导致神经元死亡、记忆和学习缺陷。本研究的目的是研究β淀粉样蛋白对作为胆固醇合成和稳态基因的调节HMGCR和ABCA1的miRNA的影响。从C57BL/6J小鼠中分离原代星形胶质细胞,并用0.5μM淀粉样蛋白β(Aβ)处理。通过实时PCR测量基因和miRNA的表达水平。与对照组相比,Aβ处理分别导致作为HMGCR和ABCA1的阳性和阴性调节因子的miR-96-5p表达显著降低。作为HMGCR的负调控因子,miR-27a-3p的表达没有显著增加。作为ABCA1负调控因子,miR-106b-5p和miR-143-3p的表达也显著降低。淀粉样蛋白β可以通过调节miRNA改变胆固醇稳态途径中主要基因的表达。
{"title":"Amyloid Beta Alters the Expression of microRNAs Regulating HMGCR and ABCA1 Genes in Astrocytes of C57BL/6J Mice.","authors":"Hossein Azizi Dariuni, Mehrnaz Karimi Darabi, Zahra Nazeri, Shirin Azizidoost, Alireza Kheiroallah, Azam Khedri, Maryam Cheraghzadeh","doi":"10.22088/IJMCM.BUMS.12.1.30","DOIUrl":"10.22088/IJMCM.BUMS.12.1.30","url":null,"abstract":"<p><p>Dysregulation of brain cholesterol homeostasis causes the accumulation of extracellular protein deposits called amyloid plaques in the hippocampus which eventually leads to neuronal death, memory and learning deficits. The aim of the present study was to investigate the effect of beta amyloid on miRNAs regulating HMGCR and ABCA1 as cholesterol synthesis and homeostasis genes. Primary astrocytes were isolated from C57BL/6J mice, and were treated with 0.5 μM amyloid beta (Aβ). Expression levels of genes and miRNAs were measured by real-time PCR. In comparison to control, Aβ treatment resulted in a significant decrease in miR-96-5p expression as a positive and negative regulator of HMGCR and ABCA1, respectively. There was no significant increase in miR-27a-3p expression as a negative regulator of HMGCR. miR- 106b- 5p and miR-143-3p expressions were also dramatically decreased as ABCA1 negative regulators. Amyloid beta can alter the expression of major genes in the cholesterol homeostasis pathway via their regulatory miRNAs.</p>","PeriodicalId":14152,"journal":{"name":"International Journal of Molecular and Cellular Medicine","volume":"12 1","pages":"30-39"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10629724/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71521381","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Inflammatory Responses of Women with Polycystic Ovary Syndrome in Vitro Differ from Healthy Women. 多囊卵巢综合征患者的炎症反应与健康女性不同。
Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2023-01-01 DOI: 10.22088/IJMCM.BUMS.12.1.70
Fatemeh Rezayat, Mehri Hajiaghayi, Nazanin Ghasemi, Mehrnaz Mesdaghi, Fahimeh Ramezani Tehrani, Nariman Mosaffa

Polycystic ovary syndrome is a low-grade inflammatory state with increased serum levels of TNF-α. The present study has compared the inflammatory responses to breast cancer cell lines in women with PCOS with healthy women. Peripheral blood mononuclear cells (PBMCs) isolated from 50 women with PCOS and 50 healthy controls were cultured in the trans-well co-culture system. These cells were stimulated with two distinct breast cancer cell lines. The proliferation of PBMCs, CD3+CD8+T cell percentages, and tumor necrosis factor-alpha (TNF-α) concentration were evaluated after 48 and 72 hours of incubation. TNF-α concentration and the proliferation rate of PBMCs after 48 hours of incubation significantly increased in the PCOS group. However, after 72 hours, TNF-α secretion significantly decreased in the PCOS group. The ability of PBMCs to produce TNF-α decreased gradually in women with PCOS. When the effects of low-grade inflammation and endocrine conditions on the cells decrease, the inability of PBMCs to create an inflammatory response will be altered.

多囊卵巢综合征是一种低度炎症状态,血清TNF-α水平升高。本研究比较了患有PCOS的女性和健康女性对乳腺癌症细胞系的炎症反应。从50名多囊卵巢综合征妇女和50名健康对照中分离的外周血单核细胞(PBMC)在跨孔共培养系统中培养。用两种不同的癌症细胞系刺激这些细胞。培养48和72小时后,评估PBMC的增殖、CD3+CD8+T细胞百分比和肿瘤坏死因子-α(TNF-α)浓度。PCOS组培养48小时后TNF-α浓度和PBMC增殖率显著升高。然而,72小时后,PCOS组的TNF-α分泌显著减少。PCOS患者PBMC产生TNF-α的能力逐渐下降。当低度炎症和内分泌条件对细胞的影响减少时,PBMC产生炎症反应的能力就会改变。
{"title":"Inflammatory Responses of Women with Polycystic Ovary Syndrome <i>in Vitro</i> Differ from Healthy Women.","authors":"Fatemeh Rezayat, Mehri Hajiaghayi, Nazanin Ghasemi, Mehrnaz Mesdaghi, Fahimeh Ramezani Tehrani, Nariman Mosaffa","doi":"10.22088/IJMCM.BUMS.12.1.70","DOIUrl":"10.22088/IJMCM.BUMS.12.1.70","url":null,"abstract":"<p><p>Polycystic ovary syndrome is a low-grade inflammatory state with increased serum levels of TNF-α. The present study has compared the inflammatory responses to breast cancer cell lines in women with PCOS with healthy women. Peripheral blood mononuclear cells (PBMCs) isolated from 50 women with PCOS and 50 healthy controls were cultured in the trans-well co-culture system. These cells were stimulated with two distinct breast cancer cell lines. The proliferation of PBMCs, CD3+CD8+T cell percentages, and tumor necrosis factor-alpha (TNF-α) concentration were evaluated after 48 and 72 hours of incubation. TNF-α concentration and the proliferation rate of PBMCs after 48 hours of incubation significantly increased in the PCOS group. However, after 72 hours, TNF-α secretion significantly decreased in the PCOS group. The ability of PBMCs to produce TNF-α decreased gradually in women with PCOS. When the effects of low-grade inflammation and endocrine conditions on the cells decrease, the inability of PBMCs to create an inflammatory response will be altered.</p>","PeriodicalId":14152,"journal":{"name":"International Journal of Molecular and Cellular Medicine","volume":"12 1","pages":"70-80"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10629727/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71521383","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of Capparis spinosa Fruit Hydroalcoholic Extract on Paraquat-Induced Pulmonary Fibrosis in the Rat. 刺山柑果实水醇提取物对百草枯诱导的大鼠肺纤维化的影响
IF 1.5 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2023-01-01 DOI: 10.22088/IJMCM.BUMS.12.4.423
Tahmine Ostovar, Sahar Rezaei, Hajar Shokri-Afra, Sadra Samavarchi Tehrani, Fatemeh Namvarjah, Masoume Aliabadi, Hosein Effatpanah, Hemen Moradi-Sardareh

Pulmonary fibrosis (PF) is a lethal inflammatory disease and there has been no effective medication for this progressive disease up to now. Paraquat is commonly used in agricultural settings to control weed growth and is one of the important risk factors for PF. Additionally, emerging evidence has demonstrated Capparis spinosa (C. spinose) fruit extract has anti-fibrotic, anti-inflammatory, and antioxidant properties. We aimed to evaluate whether C. spinose fruit hydroalcoholic extract has a positive effect against Paraquat-induced PF in rats. 30 male Wistar rats were randomly divided into 5 groups, which included: a control group, a Paraquat control group, a C. spinose group with a dose of 20 mg/kg, a C. spinose group with a dose of 30 mg/kg, a C. spinose group with a dose of 50 mg/kg. After 21 days of the treatment, levels of hydroxyproline and malondialdehyde (MDA) in lung tissue were assessed and lung indices and semi-quantitative histopathological changes were determined. The results showed that treatment with C. spinose, led to increased weight gain, whereas reduced lung weight. C. spinose demonstrated a decreasing effect on levels of MDA, and hydroxyproline in lung tissue. Moreover, histopathological data and the number of lung indices indicated the preventive role of C. spinose Paraquat-induced PF in rats.

肺纤维化(PF)是一种致命的炎症性疾病,迄今为止还没有治疗这种渐进性疾病的有效药物。百草枯常用于农业环境中控制杂草生长,是导致肺纤维化的重要风险因素之一。此外,新的证据表明,菠菜果(Capparis spinosa,C. spinose)果实提取物具有抗纤维化、抗炎和抗氧化特性。我们的目的是评估 C. spinose 果实水醇提取物是否对百草枯诱导的大鼠 PF 有积极作用。将 30 只雄性 Wistar 大鼠随机分为 5 组,包括:对照组、百草枯对照组、剂量为 20 毫克/千克的刺五加组、剂量为 30 毫克/千克的刺五加组和剂量为 50 毫克/千克的刺五加组。治疗 21 天后,对肺组织中的羟脯氨酸和丙二醛(MDA)水平进行评估,并测定肺指数和半定量组织病理学变化。结果表明,使用 C. spinose 会导致体重增加,但肺重量会减少。C. spinose 对肺组织中的 MDA 和羟脯氨酸水平有降低作用。此外,组织病理学数据和肺指数的数量表明,C. spinose 对百草枯诱导的大鼠 PF 有预防作用。
{"title":"Effect of <i>Capparis spinosa</i> Fruit Hydroalcoholic Extract on Paraquat-Induced Pulmonary Fibrosis in the Rat.","authors":"Tahmine Ostovar, Sahar Rezaei, Hajar Shokri-Afra, Sadra Samavarchi Tehrani, Fatemeh Namvarjah, Masoume Aliabadi, Hosein Effatpanah, Hemen Moradi-Sardareh","doi":"10.22088/IJMCM.BUMS.12.4.423","DOIUrl":"10.22088/IJMCM.BUMS.12.4.423","url":null,"abstract":"<p><p>Pulmonary fibrosis (PF) is a lethal inflammatory disease and there has been no effective medication for this progressive disease up to now. Paraquat is commonly used in agricultural settings to control weed growth and is one of the important risk factors for PF. Additionally, emerging evidence has demonstrated <i>Capparis spinosa</i> (<i>C. spinose</i>) fruit extract has anti-fibrotic, anti-inflammatory, and antioxidant properties. We aimed to evaluate whether <i>C. spinose</i> fruit hydroalcoholic extract has a positive effect against Paraquat-induced PF in rats. 30 male Wistar rats were randomly divided into 5 groups, which included: a control group, a Paraquat control group, a <i>C. spinose</i> group with a dose of 20 mg/kg, a <i>C. spinose</i> group with a dose of 30 mg/kg, a <i>C. spinose</i> group with a dose of 50 mg/kg. After 21 days of the treatment, levels of hydroxyproline and malondialdehyde (MDA) in lung tissue were assessed and lung indices and semi-quantitative histopathological changes were determined. The results showed that treatment with <i>C. spinose</i>, led to increased weight gain, whereas reduced lung weight. <i>C. spinose</i> demonstrated a decreasing effect on levels of MDA, and hydroxyproline in lung tissue. Moreover, histopathological data and the number of lung indices indicated the preventive role of <i>C. spinose</i> Paraquat-induced PF in rats.</p>","PeriodicalId":14152,"journal":{"name":"International Journal of Molecular and Cellular Medicine","volume":"12 4","pages":"423-434"},"PeriodicalIF":1.5,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11240055/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141616343","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of Inhibitory Effect of Abatacept (CTLA4-ig) and Conditioned Medium of Mesenchymal Stem Cell in an Acetic Acid-induced Mouse Model of Acute Colitis. 评估阿帕他赛(CTLA4-ig)和间充质干细胞条件培养基对醋酸诱导的急性结肠炎小鼠模型的抑制作用
Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2023-01-01 DOI: 10.22088/IJMCM.BUMS.12.2.159
Manizhe Faghih, Mona Moshiri, Fatemeh Ahmadzadeh, Maryam Ghasemi, Saeid Abediankenari

An individual with a genetic predisposition to inflammatory bowel disease (IBD) can experience inflammatory responses leading to conditions such as Crohn's disease (CD) or Ulcerative colitis (UC). Currently, stem cell therapies, particularly those utilizing mesenchymal stem cells (MSCs), are gaining attention due to their immunomodulatory properties, as demonstrated in clinical trials. Consequently, we decided to investigate the effects of mesenchymal stem cells-conditioned medium (MSC-CM) and Abatacept in an experimental model of acute colitis. MSC-CM was extracted from female BALB/C mice and stored for future use. Acute colitis was induced in BALB/C mice through the intrarectal administration of 100 µL of 4% acetic acid. Following this procedure, CM and Abatacept were administered intraperitoneally. Throughout the study, various parameters were monitored, including changes in body weight, bleeding, stool consistency, disease activity index (DAI), mortality rate, as well as the weight and length of the colon. Histopathological analyses were also conducted, along with monitoring changes in the levels of IL-10 and IFN-γ. The data collected are presented as mean ± SD and were analyzed using One-Way ANOVA. According to the results of the study, CM with and without Abatacept significantly reduced weight loss and bleeding as well as improved fecal consistency and DAI. Macroscopic examination of the colon showed that after infusion, colon length was reduced and histopathological analysis showed a decrease in mucosal changes. The secretion of IL-10 was increased while the IFN-γ level was reduced. Research indicates that the immunomodulatory properties of MSC secretion can have positive effects. We propose a combination therapy with MSC, which we believe could lead to improved outcomes in the treatment of acute colitis.

有炎症性肠病(IBD)遗传倾向的人可能会出现炎症反应,导致克罗恩病(CD)或溃疡性结肠炎(UC)等疾病。目前,干细胞疗法,尤其是利用间充质干细胞(MSCs)的干细胞疗法,因其免疫调节特性而备受关注。因此,我们决定研究间充质干细胞调节培养基(MSC-CM)和阿帕他赛普在急性结肠炎实验模型中的作用。间充质干细胞调节培养基是从雌性BALB/C小鼠体内提取的,储存起来以备将来使用。通过直肠内注射 100 µL 4% 乙酸诱导 BALB/C 小鼠急性结肠炎。之后,腹腔注射 CM 和阿帕他赛。在整个研究过程中,对各种参数进行了监测,包括体重、出血量、粪便稠度、疾病活动指数(DAI)、死亡率以及结肠重量和长度的变化。此外,还进行了组织病理学分析,并监测了 IL-10 和 IFN-γ 水平的变化。收集的数据以均数±标准差表示,并采用单向方差分析。研究结果表明,使用或不使用阿帕他赛普的中药均能显著减少体重下降和出血,并改善粪便稠度和 DAI。结肠的宏观检查显示,输液后结肠长度缩短,组织病理学分析显示粘膜病变减少。IL-10 的分泌增加了,而 IFN-γ 的水平降低了。研究表明,间充质干细胞分泌的免疫调节特性可产生积极影响。我们建议采用间充质干细胞联合疗法,相信这种疗法能改善急性结肠炎的治疗效果。
{"title":"Evaluation of Inhibitory Effect of Abatacept (CTLA4-ig) and Conditioned Medium of Mesenchymal Stem Cell in an Acetic Acid-induced Mouse Model of Acute Colitis.","authors":"Manizhe Faghih, Mona Moshiri, Fatemeh Ahmadzadeh, Maryam Ghasemi, Saeid Abediankenari","doi":"10.22088/IJMCM.BUMS.12.2.159","DOIUrl":"10.22088/IJMCM.BUMS.12.2.159","url":null,"abstract":"<p><p>An individual with a genetic predisposition to inflammatory bowel disease (IBD) can experience inflammatory responses leading to conditions such as Crohn's disease (CD) or Ulcerative colitis (UC). Currently, stem cell therapies, particularly those utilizing mesenchymal stem cells (MSCs), are gaining attention due to their immunomodulatory properties, as demonstrated in clinical trials. Consequently, we decided to investigate the effects of mesenchymal stem cells-conditioned medium (MSC-CM) and Abatacept in an experimental model of acute colitis. MSC-CM was extracted from female BALB/C mice and stored for future use. Acute colitis was induced in BALB/C mice through the intrarectal administration of 100 µL of 4% acetic acid. Following this procedure, CM and Abatacept were administered intraperitoneally. Throughout the study, various parameters were monitored, including changes in body weight, bleeding, stool consistency, disease activity index (DAI), mortality rate, as well as the weight and length of the colon. Histopathological analyses were also conducted, along with monitoring changes in the levels of IL-10 and IFN-γ. The data collected are presented as mean ± SD and were analyzed using One-Way ANOVA. According to the results of the study, CM with and without Abatacept significantly reduced weight loss and bleeding as well as improved fecal consistency and DAI. Macroscopic examination of the colon showed that after infusion, colon length was reduced and histopathological analysis showed a decrease in mucosal changes. The secretion of IL-10 was increased while the IFN-γ level was reduced. Research indicates that the immunomodulatory properties of MSC secretion can have positive effects. We propose a combination therapy with MSC, which we believe could lead to improved outcomes in the treatment of acute colitis.</p>","PeriodicalId":14152,"journal":{"name":"International Journal of Molecular and Cellular Medicine","volume":"12 2","pages":"159-171"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10837915/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139681097","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mesenchymal Stem Cells Therapy Led to the Improvement of Spatial Memory in Rats with Alzheimer's disease Through Changing the Expression of LncRNA TUSC7/ miR-449a/ PPARγ and CD36 Genes in the Brain Tissue. 间充质干细胞疗法通过改变脑组织中 LncRNA TUSC7/ miR-449a/ PPARγ 和 CD36 基因的表达改善阿尔茨海默病大鼠的空间记忆能力
Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2023-01-01 DOI: 10.22088/IJMCM.BUMS.12.2.108
Seyedeh Pardis Pezeshki, Mehrnaz Karimi Darabi, Zahra Nazeri, Alireza Sarkaki, Mojtaba Rashidi, Hossein Babaahmadi-Rezaei, Alireza Kheirollah, Maryam Cheraghzadeh

Mesenchymal stem cells (MSCs) have the ability to phagocytize amyloid beta (Aβ) plaques and lower inflammation through the activity of microglia. Peroxisome proliferator-activated receptor gamma (PPARγ) is a protein involved in reducing inflammation through the activity of microglia and the phagocytosis of Aβ plaques by scavenger receptor CD36, in this study, the effect of MSCs therapy on memory function and plaques was investigated. A total of 24 adult male Wistar rats were randomly divided into three groups:1) the control group, 2) the Aβ-treated group (Alzheimer's disease (AD)), and 3) the MSC-treated group (AD + MSC). After the treatment with Aβ and MSCs, western blotting and real-time polymerase chain reaction (PCR) techniques were used to assess protein and gene expression levels, respectively. MSCs improved spatial learning and memory in the AD group (p ≤0.05). The expression levels of PPARγ, lncRNA TUSC7, and CD36 genes were significantly elevated in the group receiving MSCs compared to the AD group (p≤0.0001). Also, the expression level of miR-449a significantly decreased in the AD + MSC group (p≤0.0001). Moreover, western blot analysis revealed that PPARγ and CD36 protein levels were enhanced in the AD + MSC group compared to the AD group (p≤0.0001). MSC treatment led to the positive regulation of the PPARγ gene and its protein expression by ncRNAs, which could have a beneficial impact on CD36 protein levels, and subsequently, reduce the number of plaques in the cell recipient.

间充质干细胞(MSCs)具有吞噬淀粉样β(Aβ)斑块的能力,并能通过小胶质细胞的活性降低炎症。过氧化物酶体增殖激活受体γ(PPARγ)是一种蛋白质,可通过小胶质细胞的活性和清道夫受体CD36对Aβ斑块的吞噬作用降低炎症,本研究探讨了间充质干细胞治疗对记忆功能和斑块的影响。研究人员将24只成年雄性Wistar大鼠随机分为三组:1)对照组;2)Aβ治疗组(阿尔茨海默病(AD));3)间充质干细胞治疗组(AD + 间充质干细胞)。在使用Aβ和间充质干细胞治疗后,分别使用Western印迹和实时聚合酶链反应(PCR)技术评估蛋白质和基因表达水平。间充质干细胞改善了AD组的空间学习和记忆(P≤0.05)。与AD组相比,接受间充质干细胞治疗组的PPARγ、lncRNA TUSC7和CD36基因的表达水平明显升高(p≤0.0001)。此外,miR-449a的表达水平在AD+间充质干细胞组明显下降(p≤0.0001)。此外,Western印迹分析显示,与AD组相比,AD+间充质干细胞组的PPARγ和CD36蛋白水平升高(p≤0.0001)。间充质干细胞治疗可通过ncRNAs正向调控PPARγ基因及其蛋白的表达,从而对CD36蛋白水平产生有益影响,进而减少细胞受体中斑块的数量。
{"title":"Mesenchymal Stem Cells Therapy Led to the Improvement of Spatial Memory in Rats with Alzheimer's disease Through Changing the Expression of LncRNA TUSC7/ miR-449a/ PPARγ and CD36 Genes in the Brain Tissue.","authors":"Seyedeh Pardis Pezeshki, Mehrnaz Karimi Darabi, Zahra Nazeri, Alireza Sarkaki, Mojtaba Rashidi, Hossein Babaahmadi-Rezaei, Alireza Kheirollah, Maryam Cheraghzadeh","doi":"10.22088/IJMCM.BUMS.12.2.108","DOIUrl":"10.22088/IJMCM.BUMS.12.2.108","url":null,"abstract":"<p><p>Mesenchymal stem cells (MSCs) have the ability to phagocytize amyloid beta (Aβ) plaques and lower inflammation through the activity of microglia. Peroxisome proliferator-activated receptor gamma (PPARγ) is a protein involved in reducing inflammation through the activity of microglia and the phagocytosis of Aβ plaques by scavenger receptor CD36, in this study, the effect of MSCs therapy on memory function and plaques was investigated. A total of 24 adult male Wistar rats were randomly divided into three groups:1) the control group, 2) the Aβ-treated group (Alzheimer's disease (AD)), and 3) the MSC-treated group (AD + MSC). After the treatment with Aβ and MSCs, western blotting and real-time polymerase chain reaction (PCR) techniques were used to assess protein and gene expression levels, respectively. MSCs improved spatial learning and memory in the AD group (p ≤0.05). The expression levels of PPARγ, lncRNA TUSC7, and CD36 genes were significantly elevated in the group receiving MSCs compared to the AD group (p≤0.0001). Also, the expression level of miR-449a significantly decreased in the AD + MSC group (p≤0.0001). Moreover, western blot analysis revealed that PPARγ and CD36 protein levels were enhanced in the AD + MSC group compared to the AD group (p≤0.0001). MSC treatment led to the positive regulation of the PPARγ gene and its protein expression by ncRNAs, which could have a beneficial impact on CD36 protein levels, and subsequently, reduce the number of plaques in the cell recipient.</p>","PeriodicalId":14152,"journal":{"name":"International Journal of Molecular and Cellular Medicine","volume":"12 2","pages":"108-119"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10837912/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139681101","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mutational Analysis and Genotype Investigation of Less Known Gaucher Mutations through Haplotype Analysis in Iranian Gaucher Patients. 通过单体型分析对伊朗戈谢患者中鲜为人知的戈谢突变进行突变分析和基因型调查。
Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2023-01-01 DOI: 10.22088/IJMCM.BUMS.12.1.40
Negar Sardarpour, Hamideh Bagherian, Fatemeh Zafarghandi Motlagh, Tina Shirzadeh, Sadaf Asnavandi, Shahrzad Younesikhah, Shadab Salehpour, Aria Setoodeh, Mohammad Reza Alaei, Sirous Zeinali

Gaucher's disease (GD) is the most frequent lysosomal storage disorder resulting from a deficiency of the enzyme glucocerebrosidase (GBA) which causes the accumulation of glucocerebroside. More than 500 mutations have been reported on the GBA gene so far. In this study, we aimed to investigate more on the genotype of less known mutations through haplotype analysis to explain their disease-causing inheritance. Eight patients and three carriers from nine different families were enrolled in the study. DNA sequencing of all GBA gene's exons was performed and pathogenicity of the mutations was investigated. Using GBA gene-linked STR markers, allele segregations were determined in some families. A total of six different mutations were determined. Five and three patients were identified to carry mutations in homozygous and compound heterozygote patterns respectively, three participants also were identified as carriers. The most prevalent mutations were c.1448 T>C and RecNcil, however, three less common mutations were identified (i.e., c.1223 C>T, c.1315 A>G, and c.1214 G>C). In conclusion, we evaluated six different mutations in Iranian patients and elucidated the inheritance of the three less-known mutations by linkage analysis.

戈谢病(GD)是最常见的溶酶体储存障碍,由葡萄糖脑苷酶(GBA)缺乏引起,GBA导致葡萄糖脑苷积累。到目前为止,GBA基因已有500多个突变。在这项研究中,我们旨在通过单倍型分析来更多地研究鲜为人知的突变的基因型,以解释其致病遗传。来自9个不同家庭的8名患者和3名携带者参与了这项研究。对GBA基因的所有外显子进行了DNA测序,并对突变的致病性进行了研究。利用GBA基因连锁STR标记,在一些家族中确定了等位基因的分离。总共确定了六种不同的突变。分别有5名和3名患者被鉴定为纯合型和复合杂合型突变,3名参与者也被鉴定为携带者。最常见的突变是c.1448 T>c和RecNcil,然而,发现了三种不太常见的突变(即c.1223 c>T、c.1315 A>G和c.1214 G>c)。总之,我们评估了伊朗患者的六种不同突变,并通过连锁分析阐明了三种鲜为人知的突变的遗传性。
{"title":"Mutational Analysis and Genotype Investigation of Less Known Gaucher Mutations through Haplotype Analysis in Iranian Gaucher Patients.","authors":"Negar Sardarpour, Hamideh Bagherian, Fatemeh Zafarghandi Motlagh, Tina Shirzadeh, Sadaf Asnavandi, Shahrzad Younesikhah, Shadab Salehpour, Aria Setoodeh, Mohammad Reza Alaei, Sirous Zeinali","doi":"10.22088/IJMCM.BUMS.12.1.40","DOIUrl":"10.22088/IJMCM.BUMS.12.1.40","url":null,"abstract":"<p><p>Gaucher's disease (GD) is the most frequent lysosomal storage disorder resulting from a deficiency of the enzyme glucocerebrosidase (GBA) which causes the accumulation of glucocerebroside. More than 500 mutations have been reported on the GBA gene so far. In this study, we aimed to investigate more on the genotype of less known mutations through haplotype analysis to explain their disease-causing inheritance. Eight patients and three carriers from nine different families were enrolled in the study. DNA sequencing of all GBA gene's exons was performed and pathogenicity of the mutations was investigated. Using GBA gene-linked STR markers, allele segregations were determined in some families. A total of six different mutations were determined. Five and three patients were identified to carry mutations in homozygous and compound heterozygote patterns respectively, three participants also were identified as carriers. The most prevalent mutations were c.1448 T>C and RecNcil, however, three less common mutations were identified (i.e., c.1223 C>T, c.1315 A>G, and c.1214 G>C). In conclusion, we evaluated six different mutations in Iranian patients and elucidated the inheritance of the three less-known mutations by linkage analysis.</p>","PeriodicalId":14152,"journal":{"name":"International Journal of Molecular and Cellular Medicine","volume":"12 1","pages":"40-50"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10629722/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71521400","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
International Journal of Molecular and Cellular Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1